PKKK/300/UP/023 Identifikasi Antifungal dalam produk tradisional menggunakan LCMS
- Tapis semua fasa bergerak (akueus dan organik) menggunakan penuras membran 0.45 µm dan degas dalam kukus ultrasonik selama sekurang-kurangnya 15–20 minit.
- Lakukan Auto Purge / Manual Purge setiap kali pelarut ditambah atau ditukar jenis bagi menyingkirkan buih udara.
- Pastikan garisan dasar (baseline) dan tekanan pam stabil (RSD < 2%) sebelum memulakan suntikan sampel kelompok.
- Bagi sampel matriks kapsul lembut (softgel), gunakan Chloroform kerana gelatin/minyak tidak larut dalam Methanol.
|
NPRA PUSAT KAWALAN KUALITI |
ARAHAN KERJA: IDENTIFIKASI ANTIFUNGAL DALAM PRODUK TRADISIONAL MENGGUNAKAN LCMS | |
| No. Dokumen: PKKK/300/UP/023 | Terbitan / Semakan: Terbitan 3 Semakan 0 | |
| Tarikh Kuatkuasa: 10 April 2026 | Bahagian / Unit: SPPK · Unit Penyaringan | |
0.0 SEJARAH PINDAAN & SEMAKAN
Sejarah Pindaan & Semakan Dokumen (9 entri) ▸
Terbitan 1, Semakan 1:
Menambah perenggan 6.5.7 Internal Quality Control
Mengemaskini perenggan 5.4, penolong pegawai farmasi ditukar daripada U36 / U32 kepada U7 / U6
Mengemaskini perenggan 3 Definisi
Menambah perenggan 6.3.6 Single Standard Stock Solution
Mengemaskini perenggan 6.5.5 Sequence of Injection
Mengemaskini perenggan 6.6g dengan menambah “IQC table”
Terbitan 2, Semakan 0:
Pindakan nombor dokumen PKKK/300/UAT/049 kepada PKKK/300/UP/023.
PKKK/300/UAT/013 kepada PKKK/300/UP/012
PKKK/300/UAT/001 kepada PKKK/300/UP/001
Sejarah Pindaan & Semakan Dokumen (3 entri) ▸
Mengemaskini para 7 Rekod Kualiti dengan menambah:
UP/001A Borang Persampelan
UP/006 Laporan Pengujian LCMS
1.0 TUJUAN
Untuk memastikan ujian pengesanan anti-fungal dalam produk tradisional menggunakan alat High Performance Liquid Chromatography Mass Spectrometer dilaksanakan dengan cekap dan berkesan.
2.0 SKOP
6.0 PROSEDUR
Material and Equipment
Instrument:
Triple Quadrupole LCMS – 8045 (High Performance Liquid Chromatography Mass Spectrometer Liquid Chromatography with mass spectrometry) and heated ESI as interface.
Analytical balance & microbalance
Column: Phenomenex Kinetex XB-C18 1.7µm, 100 x 2.1 mm or equivalent
Reference standards:
Fluconazole
Ketonazole
Clotrimazole
Nystatin
Griseofulvin
Econazole
Miconazole
Itraconazole
Chemicals:
Methanol (LCMS grade)
Acetonitrile with 0.1% Formic Acid (LCMS grade)
Deionised water with 0.1% Formic Acid (LCMS Grade)
Deionized water
Formic acid
Glasswares and consumables:
Beakers (50 ml)
Solvent filter system
Nylon solvent filter 0.45 µm
Solvent bottle (1 L)
Volumetric Flasks (Grade A)
Nylon syringe filter 0.45 µm
Disposable syringe without needle (5 ml)
2 ml glass screw cap vial
Preparation of Mobile Phase
Measure 900 ml of acetonitrile and transfer in solvent bottle.
Repeat step 6.2(i) and 6.2(ii) for deionized water.
Degassed filtered mobile phase at least for 30 minutes to ensure no bubble is present.
Or used ready-made mobile phase of deionised water with 0.1% Formic Acid and acetonitrile with 0.1% Formic Acid, transfer into solvent bottle and proceed to step v.
Preparation of Reference Standard
Individual Stock Standard (250 µg/ml)
Mixed Stock A (10 µg/ml)
Pipette 200 µl of each stock standard into 5 ml amber volumetric flask. Make up to mark with methanol and vortex to dissolve. Final concentration for mix stock A is 10 µg/ml.
Mixed Stock B (1.0 µg/ml)
Pipette 500 µl of mixed stock A into 5 ml amber volumetric flask. Make up to mark with methanol and vortex to dissolve. Final concentration for mix stock B is 1.0 µg/ml.
Mixed Working Standard (WS, 100 ng/ml)
Pipette 150 µl of mixed stock B and 1350 µl of methanol into a 2 ml amber vial. Vortex to dissolve. Final concentration of mixed working standard is 100 ng/ml.
Limit of detection (LOD, 50 ng/ml)
Pipette 75 µl of mixed stock B and 1425 µl of methanol into a 2 ml amber vial. Vortex to dissolve. Final concentration of LOD is 50 ng/ml.
Single Standard Stock Solution
This procedure is applicable for screening selected compounds only.
Preparation of sample
Sample handling (sampling)
Sampling process differ between different type of dosage form. Please refer to document PKKK/300/UP/001 (Proses Persampelan Ujian Penyaringan).
Sample preparation for capsule
By using disposable pipette, withdraw about 5 – 10 ml of clear supernatant layer to a syringe fitted with a 0.22 µm Nylon filter.
Pipette 0.1 ml of the above solution into 2 ml amber vial and dilute to 1 ml with methanol. Vortex to dissolve.
Warm it until the sample disperses in a 60°C water bath for 10 minutes.
By using a disposable pipette, withdraw about 5-10 ml of the sample solution to a syringe fitted with a 0.22 µm Nylon filter.
Pipette 0.5 ml of the above solution into a 2 ml amber vial and dilute to 1 ml with methanol. Vortex to dissolve.
Experimental Method
Table 1: Liquid chromatography (LC) parameters used for detection of Anti-fungal
Mobile Phase Method
Gradient program for mobile phase use for identification of anti-fungal in traditional products shown as below:
Table 2: Gradient program for mobile phase used for identification of anti-fungal in traditional products.
Mass spectrometry (MS) parameter used for identification of anti-fungal in traditional product are given in table below
Table 3: Mass spectrometry (MS) parameter used for identification of anti-fungal.
MRM parameter used for detection of anti-fungal in traditional product are given in table below.
Table 4: MRM parameter for identification of anti-fungal.
Sequence of Injection
Table 5: Sequence of injection for identification of anti-fungal.
System Suitability Test (SST) Requirement
6.5.6.1 System suitability test need to be performed for each batch run to ensure the entire system is working properly. Perform at least 6 replicate injection of working standard solution (100 ng/ml).
Acceptance criteria:
Tailing factor: Not more than, NMT 2.0.
Theoretical plate (N): Not less than, NLT 2000.
%RSD (retention time) for 6 injections of mix working standard solution: %RSD NMT 1.0%
S/N ratio of LOD solution: S/N > 3
Internal Quality Control (IQC)
Acceptance criteria for Internal Quality Control Check (IQC):
The percentage difference of retention time for LOD solution should not be more than 3 % for every batch of 5 samples.
Result Interpretation
Identification of target analyte is positive when.
The retention time of target compound(s) in the sample is similar to the working standard solution.
Confirmation of mass spectrum based on detection of the target (MRM 1) and reference ions (MRM 2). Reference ions are monitored as relative intensity is as the following:
Relative Ion Intensity (% of base peak) > 50: Tolerance ± 20%.
Relative Ion Intensity (% of base peak) 20 - 50: Tolerance ± 25%.
Testing result for each analyte is reported as NOT DETECTED in the sample when the peak area of a specific analyte in a sample solution is below the peak area of the standard solution at LOD level, 50 ng/ml (equivalent to 10 ppm in sample).
Analysis report
Each sample will have one analysis report. Report must consist of detail as below:
Sample details (Sample name, sample number and batch number)
Analysis date
Equipment parameter including equipment name, mobile phase program and LCMS system.
List and preparation procedures of RS use in analysis.
Sample preparation procedure and printed sample weight (for solid sample only)
Interpretation of result (Result: Detected/Not Detected)
Evidence of analysis must be attached together in analysis report:
Chromatogram of System Suitability (SST) on each compound and results.
Chromatogram of LOD on each compound and results.
Chromatogram of 1st and 2nd injection of sample (with minimum information of sample name, sample number, analysis method, date and time of analysis, confirmation of target ion (MRM1) and reference ion (MRM2).
IQC table
3.0 DEFINISI
4.0 CARTA ALIRAN
Tiada carta aliran untuk prosedur ini.
5.0 TANGGUNGJAWAB
Ketua Seksyen
Memastikan prosedur ini dipatuhi semasa pengujian dijalankan.
Menyemak dan mengesahkan semua laporan ujian tidak lulus yang telah disemak oleh Pegawai Farmasi termasuk laporan OOS.
Ketua Unit / Pegawai Farmasi Bertanggungjawab
Memastikan prosedur ini dipatuhi semasa pengujian dijalankan.
Menyemak dan mengesahkan semua laporan ujian yang telah disemak oleh Pegawai Farmasi termasuk laporan OOS.
Mengagihkan sampel kepada Pegawai Farmasi dan Penolong Pegawai Farmasi.
Menyelia ujian yang dijalankan oleh Pegawai Farmasi dan Penolong Pegawai Farmasi.
Menyemak laporan ujian.
Menjalankan siasatan OOS dan menyediakan laporan OOS bagi sampel gagal ujian.
Menjalakan aktiviti pengujian sampel mengikut tatacara yang telah ditetapkan.
Merekodkan bilangan ujian selepas selesai laporan ujian disiapkan untuk tujuan laporan bulanan.
Menghantar laporan ujian ke Unit Perkhidmatan Analisis untuk simpanan.
Menjalankan aktiviti pengujian sample mengikut tatacara yang telah ditetapkan.
7. REKOD KUALITI
No. Borang Tajuk
UP/001A Borang Persampelan
UP/006 Laporan Pengujian LCMS
Jadual Kromatografi & Rujukan Data
| Terbitan | Semakan | Ditulis Oleh | Disemak Oleh | Diluluskan Oleh | Tarikh Kuatkuasa |
|---|---|---|---|---|---|
| 1 | 0 | Nurul ‘Izzah Hany Ismail | Ooi Suat Hong | Ida Syazrina Ibrahim | 1 November 2024 |
| 1 | 1 | Nurul ‘Izzah Hany Ismail | Ooi Suat Hong | Ida Syazrina Ibrahim | 1 Julai 2025 |
| 2 | 0 | Nurul ‘Izzah Hany Ismail | Nurul Nadiah Noh | Ida Syazrina Ibrahim | 10 April 2026 |
| RUJUKAN | RUJUKAN |
|---|---|
| No. Dokumen | Tajuk |
| PKKK/300/UP/012 | Shimadzu High Performance Liquid Chromatography Mass Spectrometer LCMS-8045 |
| PKKK/300/UP/001 | Proses Persampelan (Ujian Penyaringan) |
| LC Parameters | LC Parameters |
|---|---|
| Column | Kinetex C18 XB |
| Dimensions and particle size | 100 x 2.1 mm, 1.7µm |
| Column Temperature | 40°C |
| Flow rate | 0.4 mL/min |
| Pressure | 440 bar |
| Injection volume | 5 µl |
| Mobile phase | Deinonised water with 0.1% Formic Acid Acetonitrile with 0.1% Formic Acid |
| Mobile phase method | Gradient program |
| Total run time (minutes) | 15.5 minutes |
| Time (minute) | Mobile phase (A) | Mobile phase (B) |
|---|---|---|
| 0.01 | 90 | 10 |
| 0.50 | 70 | 30 |
| 3.50 | 70 | 30 |
| 9.50 | 10 | 90 |
| 12.5 | 10 | 90 |
| 12.6 | 90 | 10 |
| 15.5 | 90 | 10 |
| MS Parameters | MS Parameters |
|---|---|
| Interface | ESI, 300oC |
| MS mode | Positive, MRM |
| CID Gas | Argon |
| Nebulizing Gas Flow | 3 L/min |
| Heating Gas Flow | 10 L/min |
| DL temperature | 250oC |
| Heat block temperature | 400oC |
| Drying gas flow | 10 L/min |
| MRM parameter | *refer table 4 |
| Analyte | Typical RT (min) | Acquisition Time (min) | MRM Transition (m/z)a | CE (V) |
|---|---|---|---|---|
| 1. Fluconazole | 3.277 | 0 - 6 | MRM1: 307.20 > 220.10 | 19 |
| 1. Fluconazole | 3.277 | 0 - 6 | MRM2: 307.20 > 139.00 | 39 |
| 2. Ketoconazole | 4.994 | 0 - 6 | MRM1: 531.25 > 82.050 | 50 |
| 2. Ketoconazole | 4.994 | 0 - 6 | MRM2: 531.25 > 112.10 | 45 |
| 3. Clotrimazole | 6.376 | 5 - 10 | MRM1: 277.10 > 165.05 | 23 |
| 3. Clotrimazole | 6.376 | 5 - 10 | MRM2: 277.10 > 241.10 | 28 |
| 4. Nystatin | 6.67 | 5 -10 | MRM1: 926.55 > 297.15 | 34 |
| 4. Nystatin | 6.67 | 5 -10 | MRM2: 926.55 > 107.00 | 52 |
| 5. Griseofulvin | 7.203 | 5 - 10 | MRM1: 353.20 > 165.00 | 22 |
| 5. Griseofulvin | 7.203 | 5 - 10 | MRM2: 353.20 > 285.05 | 19 |
| 6. Econazole | 7.387 | 5 - 10 | MRM1: 381.15 > 125.00 | 32 |
| 6. Econazole | 7.387 | 5 - 10 | MRM2: 383.10 > 125.00 | 29 |
| 7. Miconazole | 7.815 | 5 - 10 | MRM1: 415.05 > 159.00 | 32 |
| 7. Miconazole | 7.815 | 5 - 10 | MRM2: 417.05 > 159.00 | 31 |
| 8. Itraconazole | 9.541 | 8 - 12 | MRM1: 705.40 > 392.15 | 36 |
| 8. Itraconazole | 9.541 | 8 - 12 | MRM2: 705.40 > 432.25 | 34 |
| No. of injection | Detail |
|---|---|
| 1 | Blank solution |
| 2 | LOD solution (single injection) |
| 3 🡪 8 | Mixed WS (6 replicates injection) |
| 9 | Blank solution |
| 10 🡪 11 | Sample 1 (duplicate injection) |
| 12 | Blank solution |
| 13 🡪 14 | Sample 2 (duplicate injection) |
| 15 | Blank solution |
| 16 | LOD solution |